Skip to main content
Jon Cuthbert Profile pIcture
Jon Cuthbert

Jon Cuthbert

GrafaFounder & COO

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.

Articles by Jon Cuthbert

Grafa

Medicus Pharma files Abu Dhabi regulatory application for endometriosis trial

Medicus Pharma (NASDAQ:MDCX) submitted an Investigational New Drug (IND) application to the Department of Health, Abu Dhabi, seeking authorization to launch a genomics-enabled Phase 2a clinical trial evaluating its candidate Teverelix in women with symptomatic endometriosis.

Read more: Medicus Pharma files Abu Dhabi regulatory application for endometriosis trial
Grafa

Nexalin Technology reports positive results from neurostimulation anxiety trial

Nexalin Technology (NASDAQ:NXL) reported the successful completion of an 8-week, single-center, prospective, open-label clinical trial evaluating its proprietary 15 milliamp (mA), 77.5 Hz Deep Intracranial Frequency Stimulation (DIFS™) protocol in adults with generalized anxiety disorder and comorbid insomnia.

Read more: Nexalin Technology reports positive results from neurostimulation anxiety trial